The Gibco™ CTS™ Rotea™ system story-a case study of industry-academia collaboration

Anqi Li; David James; Rebecca Lim

doi:10.1038/s41434-021-00266-6

The Gibco^™ CTS^™ Rotea^™ system story-a case study of industry-academia collaboration

Gene Ther. 2023 Apr;30(3-4):192-196. doi: 10.1038/s41434-021-00266-6. Epub 2021 Jun 10.

Authors

Anqi Li^{1

2}, David James³, Rebecca Lim^{4

5}

Affiliations

¹ The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, Australia.
² Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia.
³ Scinogy Pty Ltd, Box Hill, VIC, Australia.
⁴ The Ritchie Centre, Hudson Institute of Medical Research, Clayton, VIC, Australia. Rebecca.Lim@monash.edu.
⁵ Department of Obstetrics and Gynaecology, Monash University, Clayton, VIC, Australia. Rebecca.Lim@monash.edu.

Abstract

The Gibco^™ CTS^™ Rotea^™ Counterflow Centrifugation System is an automated cell processing device developed for manufacturing cell therapy products. The developer (Scinogy Pty Ltd) collaborated with Thermo Fisher Scientific to successfully launch the product in late 2020, completing product development from concept to international sales in <3years. This article describes the origin story of the Rotea system and how a chance meeting between a co-inventor of the Rotea system and an academic cell biologist took the invention from a garage workshop to the world stage. We describe the contribution of academic research to the innovation value chain and importance of academic institutions being industry-ready to support such collaborations.

Publication types

Review

MeSH terms

Biomedical Research*
Commerce*
Inventions*